chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: 101°F Fever (20 hrs); Upset Stomach; Vomiting; Tiredness; Headache; This is a spontaneous report from a non-contactable consumer or other non hcp. A 68-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: 6203), via an unspecified route of administration, administered in Arm Right on 27Feb2021 (at the age of 68-Years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma from an unknown start and stop dates. Concomitant medication(s) included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: EM9809), via an unspecified route of administration, administered in right arm on 06Feb2021 04:30 (at the age of 68-years-old) as dose 1, single for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine (prior vaccination was none). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies were reported. The patient experienced 101°f fever (20 hrs), upset stomach, vomiting, tiredness and headache on 27Feb2021 03:00. The patient underwent lab tests and procedures which included body temperature: 101 fahrenheit on 27Feb2021. Treatment was reported as unknown for the reported events. The outcome of the events were reported as recovering.  No follow up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 101°F Fever (20 hrs); Upset Stomach; Vomiting; Tiredness; Headache; This is a spontaneous report from a non-contactable consumer or other non hcp. A 68-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: 6203), via an unspecified route of administration, administered in Arm Right on 27Feb2021 (at the age of 68-Years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma from an unknown start and stop dates. Concomitant medication(s) included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: EM9809), via an unspecified route of administration, administered in right arm on 06Feb2021 04:30 (at the age of 68-years-old) as dose 1, single for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine (prior vaccination was none). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies were reported. The patient experienced 101°f fever (20 hrs), upset stomach, vomiting, tiredness and headache on 27Feb2021 03:00. The patient underwent lab tests and procedures which included body temperature: 101 fahrenheit on 27Feb2021. Treatment was reported as unknown for the reported events. The outcome of the events were reported as recovering.  No follow up attempts are possible. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fatigue, Influenza like illness, Pyrexia
Clinical narrative: flu like; sweats chills; sweats chills; fever; vomiting; extreme tiredness; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 09Aug2021, this case now contains all required information to be considered valid.  This is a spontaneous report from two contactable consumers (patient's wife and patient). A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in deltoid right on 02Feb2021 08:45 (Batch/Lot Number: EL9265) as single dose for covid-19 immunisation. Patient age at vaccination was 76-year-old. Medical history included blood pressure, cholesterol and COPD (chronic obstructive pulmonary disease). Concomitant medications included lisinopril taken for blood pressure from an unspecified start date to 22May2021; pravastatin taken for cholesterol from an unspecified start date to 21May2021; salbutamol sulfate (PROAIR HFA) taken for chronic obstructive pulmonary disease from an unspecified start date to 22May2021. After 1st dose, withheld the evening of vaccine (02Feb2021) his s/s were flu like, sweats chills, fever, vomiting lasting 2-3days with extreme tiredness. Did not go to urgent care even the requested by family. Outcome of s/s were flu like was unknown. Outcome of extreme tiredness was not resolved. Outcome of other events was resolved in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: flu like; sweats chills; sweats chills; fever; vomiting; extreme tiredness; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 09Aug2021, this case now contains all required information to be considered valid.  This is a spontaneous report from two contactable consumers (patient's wife and patient). A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in deltoid right on 02Feb2021 08:45 (Batch/Lot Number: EL9265) as single dose for covid-19 immunisation. Patient age at vaccination was 76-year-old. Medical history included blood pressure, cholesterol and COPD (chronic obstructive pulmonary disease). Concomitant medications included lisinopril taken for blood pressure from an unspecified start date to 22May2021; pravastatin taken for cholesterol from an unspecified start date to 21May2021; salbutamol sulfate (PROAIR HFA) taken for chronic obstructive pulmonary disease from an unspecified start date to 22May2021. After 1st dose, withheld the evening of vaccine (02Feb2021) his s/s were flu like, sweats chills, fever, vomiting lasting 2-3days with extreme tiredness. Did not go to urgent care even the requested by family. Outcome of s/s were flu like was unknown. Outcome of extreme tiredness was not resolved. Outcome of other events was resolved in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hypoaesthesia, Nasopharyngitis
Clinical narrative: Fever 102.5; headache; chills; Cold and numb feet; body aches, particularly in leg; body aches, particularly in leg; ringing in ears; Cold and numb feet; Vaccine administered at inappropriate site; This is a spontaneous report from a contactable consumer or other non-HCP (Patient herself).  A 47-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Leg Left on 01Mar2021 11:00 (at the age of 47-years-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included high cholesterol and known allergies to shellfish. There were no concomitant medications. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient had no covid prior vaccination. The patient was not tested post vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Un-known), dose 1 via an unspecified route of administration, administered in Leg Left on 08Feb2021 02:30 PM (at the age of 47-years-old), as DOSE 1, SINGLE for covid-19 immunisation. On 01Mar2021 (time: 11:00 pm), the patient experienced fever 102.5, headache, chills, cold and numb feet, body aches, particularly in legs and ringing in ears. The patient not received treatment for the events. The outcome of the events was reported as not recovered, and the outcome of vaccine administered at inappropriate site was unknown.   No follow-up attempts were possible; information about lot/batch number could not be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Product administered at inappropriate site, Pyrexia, Tinnitus
Clinical narrative: Fever 102.5; headache; chills; Cold and numb feet; body aches, particularly in leg; body aches, particularly in leg; ringing in ears; Cold and numb feet; Vaccine administered at inappropriate site; This is a spontaneous report from a contactable consumer or other non-HCP (Patient herself).  A 47-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Leg Left on 01Mar2021 11:00 (at the age of 47-years-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included high cholesterol and known allergies to shellfish. There were no concomitant medications. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient had no covid prior vaccination. The patient was not tested post vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Un-known), dose 1 via an unspecified route of administration, administered in Leg Left on 08Feb2021 02:30 PM (at the age of 47-years-old), as DOSE 1, SINGLE for covid-19 immunisation. On 01Mar2021 (time: 11:00 pm), the patient experienced fever 102.5, headache, chills, cold and numb feet, body aches, particularly in legs and ringing in ears. The patient not received treatment for the events. The outcome of the events was reported as not recovered, and the outcome of vaccine administered at inappropriate site was unknown.   No follow-up attempts were possible; information about lot/batch number could not be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Numbness; Tingling; swelling, right arm & leg; headache; fatigue; pain and soreness; swelling, right arm & leg; This is a spontaneous report from a contactable Other HCP (patient)  A 56-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 02Feb2021 10:00 (age at the time of vaccination was 56-year-old) as dose 1, single for COVID-19 immunization. Medical history included type 2 diabetes mellitus, depression and anxiety from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing Known allergy: Sulfa, Sulfur. Concomitant medications included levothyroxine sodium (SYNTHROID); methylphenidate hydrochloride (CONCERTA); metformin, lisinopril, and alprazolam (XANAX) all concomitant medications were taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that on an unspecified date patient experienced numbness, tingling, swelling, right arm & leg, headache, fatigue, pain and soreness. These symptoms were worse with vaccine and lasted longer. No treatment was received for the event. Outcome of the events was reported as not recovered at this time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Swelling
Clinical narrative: Numbness; Tingling; swelling, right arm & leg; headache; fatigue; pain and soreness; swelling, right arm & leg; This is a spontaneous report from a contactable Other HCP (patient)  A 56-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 02Feb2021 10:00 (age at the time of vaccination was 56-year-old) as dose 1, single for COVID-19 immunization. Medical history included type 2 diabetes mellitus, depression and anxiety from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing Known allergy: Sulfa, Sulfur. Concomitant medications included levothyroxine sodium (SYNTHROID); methylphenidate hydrochloride (CONCERTA); metformin, lisinopril, and alprazolam (XANAX) all concomitant medications were taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that on an unspecified date patient experienced numbness, tingling, swelling, right arm & leg, headache, fatigue, pain and soreness. These symptoms were worse with vaccine and lasted longer. No treatment was received for the event. Outcome of the events was reported as not recovered at this time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Fatigue, Headache, Hypoaesthesia, Pain
Clinical narrative: Numbness; Tingling; swelling in right arm and leg; Headache; Fatigue; Pain and soreness; These symptoms were worse with vaccine #2 and lasted longer; This is a spontaneous report from a contactable other healthcare professional. A 56-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in right arm on 20Feb2021 (at the age of 56-year-old) as dose 2, single dose for COVID-19 immunisation. Medical history included, type 2 diabetes, depression, anxiety and had sulfa allergies from unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID); methylphenidate hydrochloride (CONCERTA); metformin; lisinopril; alprazolam (XANAX). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in right arm on 02Feb2021 (at the age of 56-year-old) as single dose for COVID-19 immunisation was in clinic. Patient previously took sulfur and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID. The patient did not receive other vaccine in four weeks. Post vaccination, the patient had not been tested for COVID. On 20Feb2021 15:00, patient experienced numbness, tingling, swelling in right arm and leg, headache, fatigue, pain and soreness. These symptoms were worse with vaccine 2 and lasted longer. Patient did not receive treatment in response to the events. Outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: Numbness; Tingling; swelling in right arm and leg; Headache; Fatigue; Pain and soreness; These symptoms were worse with vaccine #2 and lasted longer; This is a spontaneous report from a contactable other healthcare professional. A 56-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in right arm on 20Feb2021 (at the age of 56-year-old) as dose 2, single dose for COVID-19 immunisation. Medical history included, type 2 diabetes, depression, anxiety and had sulfa allergies from unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID); methylphenidate hydrochloride (CONCERTA); metformin; lisinopril; alprazolam (XANAX). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in right arm on 02Feb2021 (at the age of 56-year-old) as single dose for COVID-19 immunisation was in clinic. Patient previously took sulfur and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID. The patient did not receive other vaccine in four weeks. Post vaccination, the patient had not been tested for COVID. On 20Feb2021 15:00, patient experienced numbness, tingling, swelling in right arm and leg, headache, fatigue, pain and soreness. These symptoms were worse with vaccine 2 and lasted longer. Patient did not receive treatment in response to the events. Outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Inflammation, Loss of personal independence in daily activities, Muscle spasms
Clinical narrative: headache; develop inflammation on her back; muscle cramps; feeling numbness in half of her body; she stayed on bed for 2 days because of this; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on 19Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunization and experienced numbness in half of her body. It was reported that Patient received the second dose on 19Feb and she presented the same adverse reaction feeling numbness in half of her body, she stayed on bed for 2 days because of this. On an unspecified date in Feb2021, 5 days after receiving the second shot of the vaccine she started to have a headache and to develop inflammation on her back and muscle cramps. She has attended to her physicians office the whole week and has been unable to go to work. The events resulted in physician office visit. The outcome of the events was unknown.  No follow up attempts are possible; information on Lot/batch cannot be requested; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021215428 Pfizer
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: high temperature (102 at one point); severe headache; This is a spontaneous report from a non-contactable consumer (patient). A 77-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. Medical history included rosacea and psoriasis both from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient's historical vaccine included first dose of BNT162B2 (COVID Pfizer vaccine) on an unspecified date for covid-19 immunization. The patient experienced high temperature (102 at one point) and severe headache on an unspecified date. The patient underwent lab tests and procedures which included body temperature: high temperature (102 at one point) on an unknown date. The outcome of both the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia, Somnolence
Clinical narrative: slight fever (38.4 Celsius); felt very drowsy; tired; This is a spontaneous report from a contactable consumer or other non hcp. A 24-year-old non-pregnant female patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EJ1685) via an unspecified route of administration, administered in Arm Left on 01Mar2021 16:45 as DOSE 1,SINGLE for covid-19 immunisation at Workplace clinic. The patient medical history was not reported. There were no concomitant medications. Other vaccine in four weeks was reported as no. The patient had no covid prior vaccination. The Patient had not covid tested post vaccination. On 02Mar2021 (around 18 hours after the first does), The patient experienced slight fever (38.4 celsius), felt very drowsy and tired. The symptom stayed for 1.5 to 2 days and went away.The patient underwent lab tests and procedures which included body temperature: 38.4 centigrade on. The outcome of the event was unknown.  Response: The date I became aware of the adverse events were 02Mar2021 and 03Mar2021 where I finished my first shot on 01Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: Fever; Chills; Nausea; Fatigue; This is a spontaneous report from a contactable consumer or other non hcp (patient, self-reporting). A 74-year-old female patient received unspecified dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection Batch/Lot number and expiration dates were not reported), via an unspecified route of administration on 24Feb2021 (age at vaccination was 74 years) as dose number unknown single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 24Feb2021, after receiving the vaccine the patient experienced fever, chills, nausea and fatigue. The outcome of the nausea, fatigue was not recovered and other events was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: low grade fever off and on (up to 99.8); Achiness; Chills; Arm a little sore; This is a spontaneous report from a contactable consumer (patient) reporting herself. A 61-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6203) via an unspecified route of administration, in the left arm on 25Feb2021 at 15:30 (at the age of 61-years-old) as dose 1, single for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history includes, patient had allergies to medications, food, or other products: sulf drugs, flagyl, seasonal allergies. Concomitant medication included tacrolimus, bupropion hydrochloride (WELLBUTRIN), ibuprofen, pseudoephedrine hydrochloride (ADVIL COLD & SINUS), levothyroxine sodium (SYNTHROID) all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. It was reported that, on 25Feb2021, the patient experienced low grade fever off and on (up to 99.8), achiness, chills off and on for a couple of days and Arm a little sore. Patient had received treatment, Advil and Tylenol. The patient underwent lab tests and procedures which included body temperature: 99.8 on 27Feb2021 and sars-cov-2 test (Nasal swab): negative on 27Feb2021. Patient was uncomfortable replying to query, as this was private information for her. Outcome of the events was recovered in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: low grade fever off and on (up to 99.8); Achiness; Chills; Arm a little sore; This is a spontaneous report from a contactable consumer (patient) reporting herself. A 61-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6203) via an unspecified route of administration, in the left arm on 25Feb2021 at 15:30 (at the age of 61-years-old) as dose 1, single for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history includes, patient had allergies to medications, food, or other products: sulf drugs, flagyl, seasonal allergies. Concomitant medication included tacrolimus, bupropion hydrochloride (WELLBUTRIN), ibuprofen, pseudoephedrine hydrochloride (ADVIL COLD & SINUS), levothyroxine sodium (SYNTHROID) all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. It was reported that, on 25Feb2021, the patient experienced low grade fever off and on (up to 99.8), achiness, chills off and on for a couple of days and Arm a little sore. Patient had received treatment, Advil and Tylenol. The patient underwent lab tests and procedures which included body temperature: 99.8 on 27Feb2021 and sars-cov-2 test (Nasal swab): negative on 27Feb2021. Patient was uncomfortable replying to query, as this was private information for her. Outcome of the events was recovered in 2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: she had chills, headache like she never experienced before, and fever.; she had chills, headache like she never experienced before, and fever.; she had chills, headache like she never experienced before, and fever.; This is a spontaneous report from a non-contactable consumer reported for female friend. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were unknown. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. On 27Feb2021, after 2nd dose of COVID vaccine, the patient had chills, headache like she never experienced before and fever. The event took place after use of product. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Pyrexia
Clinical narrative: feeling really bad during the 24 hour period.; experienced 103 degree fever starting 12 hours after her first vaccine shot; This is a spontaneous report from a non-contactable consumer or other non hcp. A 46-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Not reported) via an unspecified route of administration, administered on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history included the patient was affected with COVID-19 on Nov2020 to an unknown date which required hospitalization. The patient's concomitant medications were not reported. It was reported that on an unspecified date in 2021 after 12 hours of first vaccine shot the patient experienced 103-degree fever and It was lasted about 24 hours and the patient felt really bad during the 24-hour period. On an unspecified date the patient underwent lab tests and procedures which included fever was 103 degree. The patient was recovered from the event 103-degree fever in 2021. The outcome of the event feeling really bad during the 24 hours period was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Hypersensitivity, Vaccination site erythema, Vomiting
Clinical narrative: allergic reaction; severe coughing; threw up; red spot on her left arm; This is a spontaneous report from a contactable consumer (Patient) reported for herself.  A 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL1283) dose 1 via an unspecified route of administration on 05Feb2021 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 26Feb2021 (Batch/Lot Number: EM6202) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included lung neoplasm malignant from an unknown date and unknown if ongoing. Consumer stated, "No, I just had lung cancer.", blood pressure measurement from an unknown date and unknown if ongoing, patient take blood pressure medicine and cholesterol medicine, blood cholesterol from an unknown date and unknown if ongoing I take blood pressure medicine and cholesterol medicine, lung operation from an unknown date and unknown if ongoing. It was reported that, on Feb2021, the patient has experienced allergic reaction (hypersensitivity), severe coughing (cough), threw up (vomiting) and red spot on her left arm (vaccination site erythema). Clinical course of events includes; she received the 1st and 2nd shot of covid vaccine. After she got the first dose, she had an allergic reaction, a severe coughing and she threw up and she had a red spot on her left arm. She encountered the same allergic reaction after she got her second dose of covid vaccine. Consumer stated, "What I want to do is I want to report a severe reaction to the vaccine." The first reaction I got was when I had the first shot. About 24 hours later, I was sick to my stomach and I was throwing up. At that time, I didn't think much about it because I thought first of all, I had just had lung cancer. So, I have been in the hospital and I was thinking - Okay, maybe it has something to do with that and also it started with like indigestion and my neighbor had fixed us dinner and I thought - Well maybe, I just didn't like the dinner, okay so I didn't think a lot about it. But then, last Friday when I got the second shot I had same deal where I was sick to my stomach and I am throwing up and coughing a lot and I am a little concerned about my lung surgery because I don't want to cough too much and tear any of that loose. Anyway, the other thing is that I also have a large red spot, you know like a, it's not really a rash, its just kind of a red area where they put the vaccine. Consumer stated that, yes, because it all happened with Pfizer both of my shots were from Pfizer. He also reported that, Yes and what they did is they removed a portion of my lung. The reason consumer reporting this is because she wanted others to be aware of it. The outcome for the events was unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: slightly dizzy/lightheaded; brain fog; sudden tiredness; sore arm around injection site; sudden entire face numbness (forehead, cheeks, nose, chin, lips-Not tougue or inside mouth); sudden entire face numbness (forehead, cheeks, nose, chin, lips-Not tougue or inside mouth); This is a spontaneous report from a contactable consumer or other non hcp. This Consumer (patient) reported for herself that a 38-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration, administered in Arm Left on 03Mar2021 10:30 (Age at vaccination 38 years) as dose 1, single for covid-19 immunisation. Patient had no medical history. Concomitant medication(s) included bupropion (BUPROPION) and melatonin (MELATONIN). The patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. On 03Mar2021 11:00, the patient experienced sudden entire face numbness (forehead, cheeks, nose, chin, lips-not tougue or inside mouth); sudden tiredness; 12:00, slightly dizzy/lightheaded; brain fog and sore arm around injection site. The patient was not received treatment for events. It was reported that 11:00-11:20 sudden entire face numbness (forehead, cheeks, nose, chin, lips-not tongue or inside mouth), 11:20-12:00 numbness improves, 12:00-2:30 slightly dizzy/lightheaded, "out of it," brain fog, 2:30 still slightly dizzy/lightheaded, "out of it," brain fog, sudden tiredness and felt tired for the rest of the day. Sore arm around injection site. Felt completely fine the next day. The clinical outcome of all events were recovered on unspecified date in 2021.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: slightly dizzy/lightheaded; brain fog; sudden tiredness; sore arm around injection site; sudden entire face numbness (forehead, cheeks, nose, chin, lips-Not tougue or inside mouth); sudden entire face numbness (forehead, cheeks, nose, chin, lips-Not tougue or inside mouth); This is a spontaneous report from a contactable consumer or other non hcp. This Consumer (patient) reported for herself that a 38-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration, administered in Arm Left on 03Mar2021 10:30 (Age at vaccination 38 years) as dose 1, single for covid-19 immunisation. Patient had no medical history. Concomitant medication(s) included bupropion (BUPROPION) and melatonin (MELATONIN). The patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. On 03Mar2021 11:00, the patient experienced sudden entire face numbness (forehead, cheeks, nose, chin, lips-not tougue or inside mouth); sudden tiredness; 12:00, slightly dizzy/lightheaded; brain fog and sore arm around injection site. The patient was not received treatment for events. It was reported that 11:00-11:20 sudden entire face numbness (forehead, cheeks, nose, chin, lips-not tongue or inside mouth), 11:20-12:00 numbness improves, 12:00-2:30 slightly dizzy/lightheaded, "out of it," brain fog, 2:30 still slightly dizzy/lightheaded, "out of it," brain fog, sudden tiredness and felt tired for the rest of the day. Sore arm around injection site. Felt completely fine the next day. The clinical outcome of all events were recovered on unspecified date in 2021.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Vomiting
Clinical narrative: he experienced a 100.1 fever; chills; vomiting; This is a spontaneous report from Pfizer sponsored program. A contactable 77-year-old male consumer (patient) reported that: A 77-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 01Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated the night he received his first vaccination, 01Mar2021, he experienced a 100.1 fever, chills, and vomiting. Patient stated his symptoms lasted for 2 days and now he's perfectly fine. Patient stated he is scheduled for his second vaccination on 22Mar2021. Patient stated he has an upcoming surgery scheduled 23Mar2021 and wanted to know if he could receive his second vaccination after his surgery. Patient stated he had a bad reaction to his first vaccination. The outcome of the events was reported as recovered on an unspecified date in Mar2021. The patient underwent lab tests and procedures which included body temperature: 100.1 on an unspecified date experienced a 100.1 fever.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: fever of 100 degrees; chills; muscle ache; joint ache; injection site pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ENT6204), via an unspecified route of administration in left arm on 04Mar2021 at 10:45 as dose 1, single for COVID-19 immunisation at public health clinic/veteran's administration facility. Medical history included depression from an unknown date and unknown if ongoing, hospitalized for COVID-19 on an unknown date in Dec2020 to an unknown date (This feels exactly like the real thing). Concomitant medications included fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021 at 12:00, the patient experienced fever of 100 degrees, chills, muscle ache, joint ache, injection site pain. with outcome of not recovered. The patient underwent lab tests and procedures which included fever was 100 degrees on an unknown date. The patient did not receive any treatment for the events. The outcome of the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: fever of 100 degrees; chills; muscle ache; joint ache; injection site pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ENT6204), via an unspecified route of administration in left arm on 04Mar2021 at 10:45 as dose 1, single for COVID-19 immunisation at public health clinic/veteran's administration facility. Medical history included depression from an unknown date and unknown if ongoing, hospitalized for COVID-19 on an unknown date in Dec2020 to an unknown date (This feels exactly like the real thing). Concomitant medications included fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021 at 12:00, the patient experienced fever of 100 degrees, chills, muscle ache, joint ache, injection site pain. with outcome of not recovered. The patient underwent lab tests and procedures which included fever was 100 degrees on an unknown date. The patient did not receive any treatment for the events. The outcome of the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: Fever of 101; headache; This is a spontaneous report from a contactable consumer (patient). A 68-years-old non-pregnant female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: unknown) via an unspecified route of administration on 04Mar2021 at 03:00 (at the age of 68-years-old) as a single dose for covid-19 immunization. Medical history included systemic lupus erythematosus and sulfa allergies both from an unknown date and unknown if ongoing. The patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with covid-19. Post vaccination, the patient had not been tested for covid-19. The patient's concomitant medications were not reported. The patient experienced fever of 101 and headache on an unknown date in Mar2021. The patient underwent lab tests and procedures which included body temperature: 101 on an unknown date in Mar2021. The patient did not receive any treatment. The outcome of both the events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Nausea, Pain
Clinical narrative: Fever; chills; sweating; aches; nausea; vomiting; fatigue; sore arm ((at site of injection); This is a spontaneous report from a contactable Consumer. This 28-Year-old non-pregnant female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 03Mar202 at 05:30 PM on left arm as dose 1, single for COVID-19 immunization. The medical history of the patient included allergy to dogs, cats, pollen allergy, fruit and vegetable allergy. The patient did not have covid prior vaccination and was tested for covid post vaccination. The patient's concomitant medications were not reported. It was mentioned that patient did not receive other vaccine in four weeks. On 04Mar2021 at 02:00 AM the patient received fever, chills, sweating, aches, nausea, vomiting, fatigue and sore arm (at site of injection). No treatment was received for events. The patient was recovering.  No follow-up attempt was possible. information about lot/batch number could not be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Fever; chills; sweating; aches; nausea; vomiting; fatigue; sore arm ((at site of injection); This is a spontaneous report from a contactable Consumer. This 28-Year-old non-pregnant female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 03Mar202 at 05:30 PM on left arm as dose 1, single for COVID-19 immunization. The medical history of the patient included allergy to dogs, cats, pollen allergy, fruit and vegetable allergy. The patient did not have covid prior vaccination and was tested for covid post vaccination. The patient's concomitant medications were not reported. It was mentioned that patient did not receive other vaccine in four weeks. On 04Mar2021 at 02:00 AM the patient received fever, chills, sweating, aches, nausea, vomiting, fatigue and sore arm (at site of injection). No treatment was received for events. The patient was recovering.  No follow-up attempt was possible. information about lot/batch number could not be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Influenza, Pyrexia
Clinical narrative: who experienced fever; flu; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for a patient that, A patient of unspecified age and gender received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, post vaccination the patient experienced fever and flu. The reporter wants to know if it's contagious. The outcome of the events was reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: 3/3 10:00 AM ET mild fever (99.5), fatigue, mild headache, tenderness in arm at injection site; 3/3 10:00 AM ET mild fever (99.5), fatigue, mild headache, tenderness in arm at injection site; 12 hours post-injection symptoms started3/2 10:30 PM ET mild fever, chills3/3 1:00 AM ET mild fever (100.7), chills, pain/tenderness in arm at injection site; 12 hours post-injection symptoms started3/2 10:30 PM ET mild fever, chills3/3 1:00 AM ET mild fever (100.7), chills, pain/tenderness in arm at injection site; 12 hours post-injection symptoms started3/2 10:30 PM ET mild fever, chills3/3 1:00 AM ET mild fever (100.7), chills, pain/tenderness in arm at injection site; This is a spontaneous report from a contactable consumer (Patient). A 50-year-old male received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, on 02Mar2021 at 10:15 (at the age of 50-year-old), as dose 1, single in left arm for COVID-19 immunization at Workplace Clinic. The patient's medical history was reported as none. Patient had no allergies to medications, food, or other products. Concomitant medications within 2 weeks of vaccination were reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Mar2021 at 22:30, 12 hours and 15 minutes after first dose of vaccine, the patient experienced fever (100.7), chills, pain/tenderness in arm at injection site; all for a duration of 1 day 11 hours and 15 minutes. On 03Mar2021 at 22:30 fatigue, fever (99.5); and mild headache for 11 hours and 15 minutes. Patient received treatment for adverse events with Acetaminophen (Tylenol), recommended dosage. On 04Mar2021 at 9:45 AM, the patient had no fever, slight fatigue, no headache, and no arm pain. The patient underwent lab test and procedure which included SARS-CoV-2 test: positive on an unspecified date prior to vaccination; body temperature: 100.7 on 02Mar2021; 99.5 on 03Mar2021; and no fever on 04Mar2021. The clinical outcome of the event fatigue was resolving. The patient had COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of all other events was resolved on 04Mar2021 at 9:45 AM.  No follow-up attempts are needed. No further information is expected.